This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

New CRISPR, mRNA & Genome Editing Sessions

 CRISPR, mRNA and Oligonucleotide experts rarely have the opportunity to come together in one forum to learn from each other and share ideas, because they often attend conferences focused only on their specific molecule. This year's TIDES meeting, held April 30 - May 3, 2017 in San Diego, gathers developers of mRNA, CRISPR and Oligonucleotide therapeutics to discuss common and unique challenges of these complex therapeutics and potential solutions to accelerate product development

Reserve your seat to attend TIDES 2017 to hear case studies and new data designed to help you:

  • Accelerate discovery and development efforts by understanding how mRNA, CRISPR and oligonucleotide technologies can be integrated and leveraged together.
  • Overcome common discovery and CMC challenges of mRNA, CRISPR and oligonucleotide therapeutics to advance your molecules through the pipeline.
  • Cross-fertilize ideas and best practices with CMOs and service providers who offer discovery, CMC and manufacturing services to the mRNA, CRISPR and Oligonucleotide communities.
  • Learn about key industry developments in mRNA therapeutics, CRISPR as a discovery tool, and CRISPR as a therapeutic modality.

Registration Savings Offer!

Save an extra $300 off the current rate to attend this year's meeting when you register online with VIP Code CRISPR300 by April 21 (new registrations only).